Back
Invesco S&P Emerging Markets Low Vol ETF Vs. Corbus Pharmaceuticals Holdings Industry Stock Comparison
Buy
51
EELV
Invesco S&P Emerging Markets Low Vol ETF
Last Price:
26.26
Seasonality Move:
0.15%
Sell
18
CRBP
Corbus Pharmaceuticals Holdings
Last Price:
21.00
Seasonality Move:
-9.84%
Buy
51
Invesco S&P Emerging Markets Low Vol ETF (EELV)
is a Buy
Is Invesco S&P Emerging Markets Low Vol ETF a Buy, Sell or Hold?
- The current Invesco S&P Emerging Markets Low Vol ETF [EELV] share price is $26.26. The Score for EELV is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- EELV is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
18
Corbus Pharmaceuticals Holdings (CRBP)
is a Sell
Is Corbus Pharmaceuticals Holdings a Buy, Sell or Hold?
- The current Corbus Pharmaceuticals Holdings [CRBP] share price is $20.92. The Score for CRBP is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
- CRBP is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
EELV Stock Price Chart
What is Invesco S&P Emerging Markets Low Vol ETF's stock price today?
-
The Invesco S&P Emerging Markets Low Vol ETF share price today is $26.26
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EELV is experiencing selling pressure, which indicates risk of future bearish movement.
CRBP Stock Price Chart
What is Corbus Pharmaceuticals Holdings's stock price today?
-
The Corbus Pharmaceuticals Holdings share price today is $20.92
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRBP is experiencing selling pressure, which indicates risk of future bearish movement.
EELV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.33 | Buy |
| Relative Strength Index (14 RSI): | 66.98 | Buy |
| Chaikin Money Flow: | -40654 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.24 - 25.94) | Buy |
| Bollinger Bands (100): | (23.71 - 25.23) | Buy |
CRBP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -9.22 | Sell |
| Relative Strength Index (14 RSI): | 26.63 | Sell |
| Chaikin Money Flow: | -808540 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (31.3 - 61.4) | Sell |
| Bollinger Bands (100): | (39.8 - 58.48) | Sell |
EELV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 26.02 | Buy |
| 20-day SMA: | 25.63 | Buy |
| 50-day SMA: | 24.99 | Buy |
| 200-day SMA: | 24.09 | Buy |
| 8-day EMA: | 26.03 | Buy |
| 20-day EMA: | 25.7 | Buy |
| 50-day EMA: | 25.16 | Buy |
| 200-day EMA: | 24.24 | Buy |
CRBP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 27.72 | Sell |
| 20-day SMA: | 43.43 | Sell |
| 50-day SMA: | 51.2 | Sell |
| 200-day SMA: | 37.41 | Sell |
| 8-day EMA: | 27.51 | Sell |
| 20-day EMA: | 38.64 | Sell |
| 50-day EMA: | 46.39 | Sell |
| 200-day EMA: | 38.73 | Sell |
Invesco S&P Emerging Markets Low Vol ETF Earnings Growth & EELV Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Corbus Pharmaceuticals Holdings Earnings Growth & CRBP Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.11 per share, a decrease next quarter of $0.64 per share, an increase this year of $6.97 per share, and a decrease next year of $0.83 per share.
Invesco S&P Emerging Markets Low Vol ETF Technical Analysis
| Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Corbus Pharmaceuticals Holdings Technical Analysis
| Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||